The cluster is driven entirely by passive mega-banks, which may reflect index inclusion or ETF demand rather than fundamental re-rating. Monitor for active manager participation or insider activity to confirm growing conviction. Given FENC's small market cap ($238M), even modest institutional accumulation could support the stock short-term.
Executive Summary
Three major passive institutional investors — Morgan Stanley, Wells Fargo, and UBS — increased their positions in Fennec Pharmaceuticals (FENC) during Q4 2024, collectively adding $1.5M in new holdings. Morgan Stanley doubled its stake, driving the majority of the activity. No institutions sold or reduced their positions.
Key Financial Metrics
Institutional Positions
Net institutional flow: $1.5M
▲ Buyers (3)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| Morgan Stanley | DOUBLED | +133.3% | $2.2M | $1.4M |
| Wells Fargo | ADD | +31.6% | $83.0K | $33.0K |
| UBS | ADD | +38.3% | $98.0K | $42.0K |
Key Facts
- Morgan Stanley doubled its stake in FENC, increasing holdings by 133.3% (148.5K → 346.4K shares), adding $1.4M in value.
- Wells Fargo and UBS each made ADD moves, increasing their positions by 31.6% and 38.3% respectively, with combined value addition of $75K.
- Total institutional buying amounted to $1.5M in net new value across three mega-passive firms, with no selling activity reported.
- All activity came from passive managers, suggesting possible index rebalancing or ETF inflows rather than active conviction.
Financial Impact
3 institutions accumulated $1.5M in net new positions, increasing total passive ownership value by $1.5M to $2.4M
Risk Factors
- All buying came from passive investors, which may not reflect fundamental conviction and could reverse with index flows.
- No active managers or hedge funds participated, limiting the strength of the signal.
- The total dollar amount ($1.5M net buy) is small relative to market cap, suggesting limited immediate upside pressure.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-FENC-2024-Q4 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 19, 2026 8d ago | SC 13G/A | $10.27 | awaiting T+60 | — | — |
Aug 31, 2026 8w ago | Insider Cluster | $12.03 | awaiting T+60 | — | — |
Aug 31, 2026 8w ago | Insider Cluster | $12.03 | awaiting T+60 | — | — |
Aug 11, 2026 11w ago | Press Release | $12.78 | awaiting T+60 | — | — |
Jun 15, 2026 19w ago | Press Release | $9.19 $11.65 | ▲ +26.77% | ▲ +25.77% | — |
May 22, 2026 22w ago | 8-K | $9.89 $11.87 | ▲ +20.02% | ▲ +17.30% | — |
May 18, 2026 23w ago | 8-K | $9.76 $12.06 | ▲ +23.57% | ▲ +17.28% | — |
May 14, 2026 23w ago | Press Release | $9.24 $10.94 | ▲ +18.40% | ▲ +14.81% | — |
May 7, 2026 24w ago | Press Release | $6.90 $9.59 | ▲ +38.99% | ▲ +35.15% | — |
Apr 28, 2026 25w ago | 8-K | $6.26 $9.99 | ▲ +59.58% | ▲ +55.47% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers